A small-molecule NNMT inhibitor studied primarily in preclinical metabolic and adipose-tissue models. This record separates established identity and source-linked research context from protocol or commercial fields that are not yet supportable.
FEMETRIC RECORD · PUBLIC5-Amino-1MQ
Fat LossBody CompositionMetabolic
Status
Preclinical / Research
Related
3
Sources
1
UPDATED 2026-09-13
01
Protocol references
SOURCE-LINKED
LITERATURE-DERIVED REFERENCE
Source-linked research context
No universal administration structure is inferred from the indexed literature. Open the source for the population, intervention and study design.
Route
Source dependent
Frequency
See indexed source
Duration
Not indexed
Escalation
Not established
Stage detail pending source extractionStarting and target doses are indexed. Intermediate steps are intentionally not inferred.
5-Amino-1MQ inhibits nicotinamide N-methyltransferase in experimental systems. The indexed evidence is preclinical and should not be presented as an established human protocol.
Mechanism summaries are stored with field-level source provenance for editorial audit.
07
Related research goals
08
Related peptides
01PEPTIDE
NAD+
An endogenous coenzyme central to redox chemistry and cellular energy, distinct from its oral precursor compounds.
EnergyMitochondrial HealthCellular Repair
02PEPTIDE
AOD-9604
A modified growth-hormone fragment studied in metabolic and obesity research, with limited supportive clinical efficacy data.
Fat LossWeight ManagementBody Composition
03PEPTIDE
MOTS-C
A mitochondrial-derived peptide studied in metabolic signaling, cellular stress and exercise models.